Literature DB >> 7240405

Simple, new test for rapid differentiation of the Mycobacterium fortuitum complex.

M J Casal, F C Rodriguez.   

Abstract

A simple, new test to differentiate species in the Mycobacterium fortuitum complex by determining susceptibility to pipemidic acid is described. A 20-mug pipemidic acid disk provides a rapid and reliable means of distinguishing M. fortuitum from M. chelonei.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7240405      PMCID： PMC273928          DOI： 10.1128/jcm.13.5.989-990.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  A study of nitrate reduction by mycobacteria. The use of the nitrate reduction test in the identification of mycobacteria.

Authors:  S VIRTANEN
Journal:  Acta Tuberc Scand Suppl       Date:  1960

Review 2.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

3.  Diagnostic key to mycobacteria encountered in clinical laboratories.

Authors:  L G Wayne; J R Doubek
Journal:  Appl Microbiol       Date:  1968-06

4.  A co-operative numerical analysis of rapidly growing mycobacteria.

Authors:  G P Kubica; I Baess; R E Gordon; P A Jenkins; J B Kwapinski; C McDurmont; S R Pattyn; H Saito; V Silcox; J L Stanford; K Takeya; M Tsukamura
Journal:  J Gen Microbiol       Date:  1972-11

5.  Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli.

Authors:  V L Sutter; S M Finegold
Journal:  Appl Microbiol       Date:  1971-01

6.  Ten mycobacterial pathogens.

Authors:  E H Runyon
Journal:  Tubercle       Date:  1974-09
  6 in total
  8 in total

1.  In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.

Authors:  M Casal; F Rodriguez; M Benavente; M Luna
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.

Authors:  R J Wallace; G Bedsole; G Sumter; C V Sanders; L C Steele; B A Brown; J Smith; D R Graham
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole.

Authors:  M Casal; F Rodriguez
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.

Authors:  R J Wallace; V A Silcox; M Tsukamura; B A Brown; J O Kilburn; W R Butler; G Onyi
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

5.  Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

6.  Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.

Authors:  L C Steele; R J Wallace
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.

Authors:  M J Casal; F C Rodriguez; M C Benavente
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

8.  Identification of Mycobacterium fortuitum and Mycobacterium chelonei.

Authors:  V Lévy-Frébault; M Daffé; K S Goh; M A Lanéelle; C Asselineau; H L David
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.